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Conserved metabolite regulation of stress granule
assembly via AdoMet
Kyle Begovich1,2, Anthony Q. Vu3,4,5, Gene Yeo3,4,5, and James E. Wilhelm1,2
Stress granules (SGs) are evolutionarily conserved condensates of ribonucleoproteins that assemble in response to metabolic
stresses. Because aberrant SG formation is associated with amyotrophic lateral sclerosis (ALS), understanding the connection
between metabolic activity and SG composition can provide therapeutic insights into neurodegeneration. Here, we identify
17 metabolic enzymes recruited to yeast SGs in response to physiological growth stress. Furthermore, the product of one of
these enzymes, AdoMet, is a regulator of SG assembly and composition. Decreases in AdoMet levels increase SG formation,
while chronic elevation of AdoMet produces SG remnants lacking proteins associated with the 59 end of transcripts.
Interestingly, acute elevation of AdoMet blocks SG formation in yeast and motor neurons. Treatment of ALS-derived motor
neurons with AdoMet also suppresses the formation of TDP-43–positive SGs, a hallmark of ALS. Together, these results argue
that AdoMet is an evolutionarily conserved regulator of SG composition and assembly with therapeutic potential in
neurodegeneration.
Introduction
Cells deploy a variety of mechanisms to fine-tune biochemical
processes in response to environmental stressors. One of these
mechanisms is the formation of stress granules (SGs), evolu-
tionarily conserved, cytoplasmic condensates comprising non-
translating mRNPs (Panas et al., 2016; Protter and Parker, 2016).
SGs assemble in response to a variety of nutrient and metab-
olic stresses and are believed to provide a mechanism for cou-
pling metabolic stress to posttranscriptional gene regulation
(Kedersha et al., 2002; Khong et al., 2017; Panas et al., 2016;
Protter and Parker, 2016). Furthermore, SGs act as centers to
regulate cell signaling outputs and protein folding, highlighting
SGs as global integrators of the stress response (Arimoto et al.,
2008; Harding et al., 2000; Kedersha et al., 2013; Wippich et al.,
2013). SGs are transient and require tight regulation of both
assembly and disassembly for cell function and viability. Con-
sistent with this, disruption of SG formation decreases cell
survival when the stress is removed (Eisinger-Mathason et al.,
2008; Kim et al., 2012; Kwon et al., 2007; Orrù et al., 2016; Yang
et al., 2014).
In addition to their role in integrating the cellular stress re-
sponse, SGs have been implicated in a variety of neurodegen-
erative disorders. Mutations in the SG components FUS (fused
in sarcoma) and HNRNPA2B1, as well as TARDBP (encoding
transactive response DNA binding protein 43 kD [TDP-43]) have
been linked to amyotrophic lateral sclerosis (ALS) and fronto-
temporal dementia (FTD; Kim et al., 2013; Kwiatkowski et al.,
2009; Martinez et al., 2016; Sreedharan et al., 2008; Vance
et al., 2009). Interestingly, pathogenic mutations in these genes
all cluster in regions that encode low-complexity sequences
(LCSs) or intrinsically disordered regions (IDRs; Chen-Plotkin
et al., 2010; Ryan et al., 2018; Shang and Huang, 2016). These
pathogenic IDR and LCS domains drive recruitment of the pro-
teins into SGs and alter the dynamics and composition of SGs that
form in response to the altered protein (Decker et al., 2007; Gilks
et al., 2004; Kato et al., 2012; Kim et al., 2013; Ling et al., 2013;
Murakami et al., 2015; Patel et al., 2015; Protter et al., 2018; Ryan
et al., 2018). Consequently, dysregulation in SG dynamics in ALS
patients results in accumulation of atypical cytoplasmic, SG-like
protein aggregates in dying neurons of the brain and spinal cord.
Furthermore, accumulation of cytoplasmic TDP-43 in aberrant
motor neuron (MN) SGs is considered a hallmark of ALS
(Bentmann et al., 2012; Blokhuis et al., 2013; Farg et al., 2013;
Keller et al., 2012; Kim et al., 2013; Liu-Yesucevitz et al., 2010).
These results argue that understanding how SGs assemble
in response to metabolic or nutrient stresses is critical for
both understanding the pathophysiology of ALS and FTD and
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developing treatment strategies focused on disrupting the for-
mation of aberrant SGs.
The current model for SG formation is that cellular stresses
promote liquid–liquid phase separation (LLPS) of mRNPs via
different multivalent interactions (Banani et al., 2017; Jain et al.,
2016; Van Treeck et al., 2018; Wheeler et al., 2016). For instance,
stress-induced disassociation of polysomes from translating
mRNAs is thought to create a scaffold that can drive LLPS in two
complementary ways (Panas et al., 2016; Protter and Parker,
2016). First, the exposure of sequences within the mRNA al-
lows RNA–RNA interactions to help drive LLPS. Additionally,
the recruitment of proteins with IDRs or LCSs to the exposed
transcript can drive LLPS via protein–protein interactions. To-
gether, these two mechanisms can greatly increase the number
of mRNP interaction sites driving LLPS and SG formation.
Consistent with thismodel, alterations in the protein levels of SG
components, posttranslational modifications within IDRs, or
LCSs of SG proteins regulate both protein–protein interactions
and SG assembly (Hilliker et al., 2011; Hofweber et al., 2018;
Swisher and Parker, 2010; Tsai et al., 2016, 2017).
Given the linkage between SGs and several neurodegenera-
tive diseases, the composition of the SG proteome has been a
subject of intense focus to identify potential therapeutic targets.
Unfortunately, large-scale biochemical studies have found that
SG composition is not only stress specific, but also organismal
and cell type specific (Jain et al., 2016; Markmiller et al., 2018).
Furthermore, these studies also revealed that SGs contain two
distinct phases: a solid-like core and a dynamic surrounding
shell (Jain et al., 2016; Markmiller et al., 2018). Although dif-
ferent mass spectrometry techniques have helped identify
which components reside within each phase, the relative role of
SG core proteins and shell proteins in SG formation and path-
ogenesis remains unclear.
Despite the fact that SG formation and composition is stress
specific, there has been surprisingly little exploration of the
connections betweenmetabolism and SG assembly. To date, only
a few metabolic enzymes have been shown to be enriched or
localized to SGs via proteomic and/or targeted studies (Jain et al.,
2016; Noree et al., 2019; Saad et al., 2017). This deficit is likely
due to the limited number of stress conditions that have been
used in SG proteomic studies. Interestingly, the localization of
one metabolic enzyme, pyruvate kinase (Cdc19), to SGs has been
shown to be crucial for reactivation of growth-promoting pathways
upon removal of stress (Grignaschi et al., 2018; Saad et al., 2017). This
suggests that SGs can play a critical role in regulating metabolic
enzymes in response to stress. There are also limited examples of the
reverse mode of regulation: metabolic intermediates that modulate
SG assembly. Whereas SGs can assemble upon the removal of glu-
cose or amino acids (Aguilera-Gomez et al., 2017; Reineke et al.,
2018), only one metabolite from intermediate metabolism, acetyl-
CoA, has been implicated in regulating SG formation (Rollins et al.,
2017). Thus, the identification of metabolic enzymes that are re-
cruited to SGs in a stress-specific manner would identify new
linkages between SG formation andmetabolism as well as provide a
novel set of potential therapeutic targets for ALS and FTD.
Here, we have identified 17 metabolic enzymes that are re-
cruited to yeast SGs in a stress-specific manner. Interestingly,
S-adenosylmethionine (AdoMet), the product of one these en-
zymes, is a regulator of SG assembly and composition. The
regulation of yeast SG formation by AdoMet is biphasic, with
chronic changes altering SG composition and acute elevation of
AdoMet suppressing SG assembly. Additionally, acute elevation
of AdoMet suppresses SG formation in MNs, demonstrating
conserved metabolite regulation of SG assembly from yeast to
humans. The suppressive effect of AdoMet on SG formation also
occurs in induced pluripotent stem cell (iPSC)-derived MNs
from ALS patients. Most provocatively, AdoMet blocks the re-
cruitment of cytoplasmic TDP-43 to remnant SGs in this cell
culture model of ALS, implying that AdoMet can modify the
pathogenic accumulation of SG material. Together, these results
argue that metabolic activity controls both the composition and
extent of SG formation and provide a framework for the iden-
tification of lead compounds that can modify or suppress SG
formation.
Results
A subset of metabolic enzymes preferentially localize to SGs
Although SGs are known to assemble in response to a variety of
nutrient and metabolic stresses, little is known how metabolic
activity is linked to SG formation. That a number of metabolic
enzymes self-organize into structures under conditions that also
trigger the formation of SGs and processing bodies (P-bodies)
suggests that the assembly of metabolic structures and RNA
granules could be connected (Narayanaswamy et al., 2009;
Noree et al., 2010, 2019). Consistent with this, three metabolic
enzymes in the de novo purine biosynthetic pathway were re-
cently discovered to localize to SGs upon growth to stationary
phase (Noree et al., 2019). To explore the extent of metabolic
enzyme recruitment to SGs, we screened all 34 knownmetabolic
enzymes that form cytoplasmic foci for recruitment to SGs and/
or P-bodies. Each metabolic enzyme was endogenously tagged
with GFP, and the extent of enzyme recruitment to RNA gran-
ules was assayed at either 1 or 5 d of growth using Ded1-mCherry
(SGmarker) or Edc3-mCherry (processing-body [P-body]marker)
expressed from its endogenous locus (Fig. 1). This screen iden-
tified 17 new metabolic enzymes that exhibited >15% colocaliza-
tion with either type of RNA granule (Fig. 1 and Table S1).
Whereas all 17 enzymes preferentially localized to SGs compared
with P-bodies, 3 enzymes (Gly1, Gre3, and Pro3) were also en-
riched in P-bodies. Of the 17 enzymes we identified, 4 enzymes
(Cdc19, Cys4, Sam1, and Sam2) were also found to be enriched in
SGs from previous proteomic and targeted studies (Table S2 and
Table S3; Jain et al., 2016; Saad et al., 2017). These results sig-
nificantly broaden the number of metabolic enzymes recruited to
SGs beyond those identified by prior proteomic and targeted
studies (Table S2 and Table S3).
Our screen also revealed two distinct patterns of SG re-
cruitment. 10 metabolic enzymes (Ade16, Ade17, Ald6, Gdh1,
Gly1, Gre3, Hem13, Sam1, Sam2, and Pro3) were recruited di-
rectly to SGs. However, seven enzymes (Cdc19, Cys4, Dph2,
Hem2, Imd3, Shm2, and Tpi1) had the ability to form structures
independent of SGs, suggesting that this class of enzymes might
form structures that are in turn recruited to SGs. Consistent
Begovich et al. Journal of Cell Biology 2 of 22
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with this interpretation, enzymes in this class such as Cys4 and
Cdc19 show a decline in the number of SG-independent struc-
tures at 5 d of growth compared with 1 d, as the number of cells
with SGs increases on this time scale (Table S1).
Because RNA granules are enriched in proteins with IDRs and
LCSs (Decker et al., 2007; Jain et al., 2016; Kato et al., 2012), we
also examined whether any of these motifs were present and/or
enriched in either class of SG associated metabolic enzymes. 12
of the 17 enzymes localized to SGs were predicted to contain an
IDR and/or LCS; however, these motifs were found at an equal
frequency among the 17 enzymes in our screen that were not
recruited to RNA granules (Table S2 and Table S3). Thus, neither
the ability to be recruited to a SG nor the pattern of recruitment
can be predicted by the presence or absence of IDRs or LCSs.
Figure 1. Metabolic enzymes localize to RNA granules during late growth stages. (A) Illustration of workflow for RNA granule screen. (B) Representative
fluorescence images of endogenously expressed GFP-tagged metabolic enzymes and mCherry-tagged Ded1 (SGs) or Edc3 (P-bodies) from either 1-d (Ade17-
GFP, Cdc19-GFP, Cys4-GFP, Sam1-GFP) or 5-d (Gly1-GFP, Pro3-GFP, Trr1-GFP) time points. Scale bar is 5 µm.
Begovich et al. Journal of Cell Biology 3 of 22
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Furthermore, only five of our SG associated enzymes have been
annotated as having RNA binding activity by high-throughput
screens (Table S2) implying that the majority of these enzymes
are not recruited to SGs via RNA. Together, these results suggest
that recruitment of metabolic enzymes to RNA granules occurs
via novel, uncharacterized mechanisms.
The metabolic enzyme Sam1 is a stress-specific component
of SGs
Recruiting metabolic enzymes to SGs represents potential way
to couple SG assembly to changes in metabolic activity/stress. If
this were the case, one might expect that the recruitment of
metabolic enzymes to SGs would be stress specific. While our
screen focused on standard growth stresses, including growth to
postdiauxic shift (1 d) or growth to stationary phase (5 d) in rich
medium, most studies of SGs focus on the effects of acute energy
stresses on log-phase cells. This raised the possibility that this
set of metabolic enzymes had beenmissed in prior studies of SGs
because their recruitment is stress specific. To test this possi-
bility, we examined whether one of the enzymes identified in
our screen, S-adenosylmethionine synthetase 1 (Sam1; Figs. 1 B
and 2, A and B), is recruited to SGs in response to acute energy
stresses. In addition to its high degree of colocalization with SGs,
we chose to focus on Sam1 because its substrates and products
(methionine, ATP, and AdoMet) are highly used and connected
to multiple metabolic pathways. Whereas Ded1-positive SGs
readily formed in log-phase yeast that were treated with sodium
azide or ethanol or shifted to medium lacking glucose, Sam1-GFP
remained diffuse under all of these conditions (Fig. 2, C and D). It
is worth noting that proteomic studies of the yeast SG identified
Sam1 as a component of SGs that form in response to sodium
azide (Jain et al., 2016). Thus, although Sam1 is not localized or
enriched in SGs above background in our visual assay, it could
still be present in SGs.
Because all of these stresses were acute energy stresses, we
also tested the effects of translational stress on Sam1 recruitment
to SGs. Given the role of methionine in translation initiation, we
reasoned that acute methionine limitation may also trigger SG
assembly. Sam1 catalyzes the ATP-dependent conversion of
methionine to AdoMet (Fig. 2 A); thus, methionine limitation
might be expected to both trigger SG assembly and regulate
Sam1 activity and/or recruitment to SGs. Whereas shifting log-
phase yeast to medium lacking methionine robustly triggered
the assembly of Ded1-containing SGs, the SGs did not accumulate
Sam1 above background levels (Fig. 2, C and D). Thus, methio-
nine limitation constitutes a previously unidentified trigger for
SG assembly; however, it is not a trigger for Sam1 enrichment
in SGs.
Given these results, we next explored whether we could
bypass the stress-specific recruitment of SGs by manipulating
the levels of SG components. Overexpression of particular SG
components can nucleate SG assembly in the absence of an ex-
ternal stress (Hilliker et al., 2011; Swisher and Parker, 2010). For
instance, overexpression of either Ded1 or Pbp1 triggers the as-
sembly of SGs in unstressed log-phase cells (Fig. 2, E and F).
However, these SGs are not enriched in Sam1. Thus, merely
triggering the aggregation of SG proteins is insufficient to
recruit Sam1. Because Sam1 has a short LCS motif typical of SG
nucleators, we also tested whether overexpression of Sam1 could
trigger SG assembly. Overexpression of Sam1 in log-phase yeast
did not cause protein aggregation or trigger SG formation (Fig. 2,
E and F). Thus, Sam1 does not have a high propensity to ag-
gregate in vivo. Consistent with this, we also found that Sam1
was recruited to only 30% of SGs formed in response to heat
shock, while the majority of the protein remained diffuse (Fig. 2,
G–I). Together, these results argue Sam1 is a stress-specific
component of SGs, but it is not capable of nucleating SGs on
its own.
Decreased levels of AdoMet trigger SG assembly and
Sam1 recruitment
The stress-specific localization of Sam1 to SGs suggested that the
products of Sam1 might play a role in modulating SG assembly.
To test this possibility, we leveraged previous structure function
studies of the Escherichia coli orthologue of Sam1, MetK, to design
a set of mutations that disrupts the enzyme’s activity (Taylor
and Markham, 1999, 2000). Although each mutation resulted in
a decrease in enzymatic activity of MetK, we used mutants that
would disrupt enzyme tetramerization (C91Y) or ATP hydrolysis
(D121N) or have no additional effect (K252M; Fig. S1 A). Each
mutation was introduced into the endogenous SAM1 locus and
assayed for its effects on SG formation.
All three SAM1-inactivating mutations caused a threefold
increase the assembly of SGs that were positive for two SG
markers (Ded1 and Pbp1) and three metabolic enzymes (Sam1,
Sam2, and Ade17; Fig. 3 A). Interestingly, both the C91Y and
K252M mutations displayed no defects in Sam1 recruitment,
while the ATP hydrolysis mutant, D121N, significantly reduced
Sam1 localization to SGs (Fig. S1, B and C). Sam2’s recruitment to
SGs was also disrupted in the SAM1 D121N allele, whereas Ade17,
Ded1, and Pbp1 remained unaffected (Fig. S1, D and E). These
results argue that the inactivation of Sam1, rather than disrup-
tion of its localization to SGs, is responsible for the increase in
SG formation observed in all three SAM1 mutations.
A potential way for Sam1 to regulate SG assembly would be to
alter the levels of various SG components. Although the effects
of Sam1 inactivation on Sam1 protein levels are allele dependent,
all three SAM1 mutations caused an ∼2.5-fold increase in Ded1
levels and a two- to fourfold increase in Sam2 protein, but had
no effect on Ade17 levels (Fig. 3, B and C). However, this increase
in Ded1 protein levels was not due to transcriptional up-
regulation (Fig. 3 D). Because overexpression of Ded1 can trig-
ger SG assembly during log phase, this result suggested that one
of the ways that Sam1 activity controls SG formation is via
posttranscriptional regulation of Ded1 levels at growth to 1 d.
One way that the levels of the SG nucleator, Ded1, could be
coupled to Sam1 activity is via the levels of AdoMet. To test this
possibility, we first sought to determine if intracellular AdoMet
levels were reduced in the SAM1 D121N allele. Consistent with
our prediction, AdoMet levels were reduced by ∼50% when
SAM1 D121N allele was grown for 24 h (Fig. S2 A). Next, if this
were the case, exogenous AdoMet would be predicted to restore
the SG formation in SAM1 mutations to WT levels. To test this,
we supplemented cultures of WT and mutant SAM1 strains with
Begovich et al. Journal of Cell Biology 4 of 22
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250 µM AdoMet and assayed its effects on SG formation and
Ded1 protein levels when grown for 24 h. In WT strains, exog-
enous AdoMet had no effect on the expression level of Ded1 or
the frequency of SG formation, as indicated by Sam1-GFP and
Ded1-mCherry (Fig. 3, E and F). In contrast, AdoMet treatment
increased intracellular levels of AdoMet, restoring both protein
levels of Ded1 and the frequency of SG formation toWT levels for
all three SAM1 loss-of-function mutations (Fig. 3, E and F; and
Fig. S2 A). These results argue that decreases in AdoMet likely
increase SG formation by elevating Ded1 protein levels.
Prolonged AdoMet accumulation disrupts SG assembly
AdoMet regulates SG accumulation under the same growth
stress that triggers the recruitment of Sam1. This suggested that
Figure 2. Recruitment of Sam1 to SGs is stress specific. (A) Diagram of methionine biosynthesis/recycling pathway in S. cerevisae. (B) Percentage of cells
with Sam1-GFP foci and Ded1-GFP foci at different growth stages. Data are presented as average ± SEM of three independent replicates. (C) Percentage of
logarithmically growing cells that form Ded1-GFP or Sam1-GFP foci upon exposure to different acute stresses. (D) Representative fluorescence images from C.
(E) Percentage of logarithmically growing cells that form Ded1-GFP or Sam1-GFP foci in response to overexpression of SG nucleator proteins (Ded1 or Pbp1) or
Sam1. (F) Representative fluorescence images from E. (G) Percentage of logarithmically growing cells that formDed1-GFP or Sam1-GFP foci after a 10-min heat
shock at 46°C. (H) Representative fluorescence images from G. (I) Representative fluorescence images of Sam1 colocalization with SGs (Ded1) under heat
shock conditions. Bar graphs in C, E, and G are presented as average ± SEM of three individual replicates. Scale bars in D, F, H, and I are 5 µm.
Begovich et al. Journal of Cell Biology 5 of 22
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Figure 3. Decreased AdoMet levels result in increased SG formation. (A) Percentage of cells forming foci in strains endogenously expressing either mutant
or WT Sam1-GFP with RFP-tagged metabolic enzymes (Sam2, Ade17) and SG markers (Ded1, Pbp1) in 1-d cultures. (B)Western blot analysis from strains used
in A at 1-d time point. Numbers below eachmutant indicate clone number for that genotype. (C)Quantification of proteins levels from B. Protein expression for
each protein is normalized to the WT sample. (D) Quantification of mRNA levels using qPCR analysis fromWT and mutant Sam1 alleles. (E) Percentage of cells
forming foci in strains supplemented with 250 µM AdoMet and endogenously expressed WT or mutant Sam1-GFP alleles and Ded1-mCherry at 1-d growth.
(F)Western blot analysis from strains used in E at 1-d time point. (G)Quantification of proteins levels from E. Protein expression is normalized to non–AdoMet-
treated Sam1 and Ded1 within their respective genotype. Bar graphs in A, C–E, and G are presented as average ± SEM of three independent replicates. Pgk1 was
used as a loading control in B and F. Statistical significance in A, C–E, and G was determined by one-tailed paired Student’s t test (*, P < 0.05).
Begovich et al. Journal of Cell Biology 6 of 22
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AdoMet might have an autoregulatory role in SG assembly when
cells are grown under chronic nutrient stress. If this were true,
one would expect that increases in AdoMet levels might block or
greatly reduce SG formation at growth to 1 d. However, because
AdoMet uptake is glucose dependent, our ability to increase
AdoMet levels above normal is limited at the 1-d time point. As a
result, we applied a genetic approach to manipulating AdoMet
levels. Deletion of ADO1 has been previously found to increase
AdoMet levels by sevenfold at 1 d of growth compared with WT
(Kanai et al., 2013). This suggested that deletion of ADO1 might
suppress SG formation. Consistent with this, deleting ADO1
resulted in an approximately sixfold increase in AdoMet con-
centration and almost completely blocked the formation of Ded1-
containing SGs at 1 d of growth (Fig. 4 A and Fig. S2 A).
One potential mechanism for the effect of ado1Δ on SGs is that
increasing AdoMet levels at this time point decreases Ded1 ex-
pression. Consistent with this interpretation, we found that
deletion of ADO1 decreases protein levels of Ded1 by 70% (Fig. 4,
B and C). Furthermore, the decrease in Ded1 protein levels oc-
curred despite DED1 mRNA levels increasing by 50% in ado1Δ
strains (Fig. 4 D). Consistent with transcript levels from Sam1
inactivation strains, this argues that the effect of AdoMet on
Ded1 expression is posttranscriptional. Additionally, even
though Ded1 is a substrate for argininemethyltransferase, Hmt1,
the posttranscriptional effects we observe are not mediated by
Hmt1 or its target residues in Ded1, implying that these effects
occur via a novel AdoMet-controlled pathway (Erce et al., 2013;
Low et al., 2013; Fig. S3, A and B).
The striking effect of elevated AdoMet levels on Ded1 ex-
pression raised the possibility that AdoMet might be regulating
composition and/or levels of multiple RNA granule components
at growth to 1 d. To test this possibility, we examined the effects
of ado1Δ on the localization of two P-body markers, Edc3 and
Dcp2, as well as five additional SG proteins, eIF4E, eIF4G1, Pab1,
Pbp1, and Pub1. Deletion of ADO1 had no effect on P-body for-
mation (Fig. S3, C and D). Thus, ado1Δ strains do not have a
generalized defect in RNA granule assembly. In contrast to its
effect on P-bodies, ado1Δ had selective effects on the recruitment
of proteins to SGs. Pab1, Pbp1, and Pub1 were all recruited
normally into SGs in the ado1Δ strain (Fig. 4 A). Thus, ado1Δ-
mediated down-regulation of Ded1 does not eliminate SGs
completely. In contrast, ado1Δ largely blocked the recruitment of
eIF4E and eIF4G1 to SGs (Fig. 4 A). Interestingly, eIF4G1 protein
levels were reduced by 50% in the ado1Δ strain, whereas eIF4E
exhibited only a mild 10% reduction in protein expression
(Fig. 4, B and C). Thus, ado1Δ down-regulates two components of
SGs and blocks the recruitment of a third component, eIF4E.
If Sam1 participated in a feedback loop regulating SG as-
sembly at growth to 1 d, one might expect that alterations in
AdoMet levels would regulate Sam1 recruitment to SGs. To test
this possibility, we examined the localization of four metabolic
enzymes (Sam1, Ade17, Cdc19, and Cys4) in an ado1Δ strain
background. Sam1 and Ade17 both failed to form foci when ADO1
was deleted (Fig. S3 E). In contrast, Cdc19 and Cys4 both formed
foci at normal levels. Unlike Ded1, the amount of all four proteins
were either unchanged or elevated by the deletion of ADO1 (Fig.
S3, F and G). Furthermore, Cdc19 and Cys4 foci both colocalized
with Pbp1-mRuby in ado1Δ strains, indicating that the structu-
res are SG remnants (Fig. S3, H–K). Thus, AdoMet levels regu-
late the recruitment of a subset of metabolic enzymes to
SG at growth to 1 d, including the enzyme that synthesizes
AdoMet, Sam1.
AdoMet supplementation suppresses acute stress-induced
SG assembly
Because the recruitment of metabolic enzymes to SGs is specific
to growth to 1 d, we next investigatedwhether deleting ADO1 had
effects on the assembly of SGs regardless of the stress. Shifting
yeast to medium lacking glucose, treatment with sodium azide,
or heat shock, all triggered Ded1-SG assembly at the same fre-
quency in WT and ado1Δ strains (Fig. 4, E and F). The failure of
ado1Δ to suppress SG assembly during log phase was surprising,
since AdoMet levels increased 50% during log phase (Fig. S2 B).
This suggested that either the effect of AdoMet on SG assembly
might be stress specific and have no effect on acute stress-
induced SGs or this increase in AdoMet levels might not be
sufficient to reduce SG formation under these conditions. To
explore the second possibility, we grew WT yeast in medium
supplemented with 250 µM AdoMet and then treated them az-
ide. AdoMet treatment caused a reduction in the both the per-
centage of cells with foci and the number of foci per cell, as
assayed with four different SG markers, Ded1, eIF4G1, Pab1, and
Pub1 (Fig. 5, A–C). Intracellular AdoMet levels were significantly
higher in AdoMet-supplemented cultures compared with un-
treated WT and ado1Δ strain (Fig. S2 B). Interestingly, unlike the
effects we observed in ado1Δ strains, AdoMet treatment had no
effect on the protein level of Ded1 or the other SG proteins we
used as markers (Fig. 5 D). Shorter incubations with AdoMet
were also effective. Treating cells for either 30 or 60 min with
AdoMet before stress resulted in a significant reduction in SG
formation, whereas a 15-min incubation failed to suppress SG
formation (Fig. S4 C). Additionally, AdoMet-mediated SG sup-
pression was not dependent on Hmt1 arginine methylation
(Fig. 5, E–G). This suggests that AdoMet plays a critical role in
suppressing SG assembly independent of protein levels or ar-
ginine methylation.
AdoMet’s ability to suppress azide-induced SGs raised the
question of whether it could suppress SG assembly in response
to other canonical stresses. Shifting AdoMet-supplemented
cultures to medium lacking glucose prevented SG assem-
bly (Fig. S4 A). However, we observed no difference in heat
shock–induced SGs when cultures were grown with exogenous
AdoMet (Fig. S4 B). Thus, while AdoMet treatment suppresses
SGs that form in response to acute energy stress, heat shock–
induced SG assembly occurs via a different pathway.
One possible way that AdoMetmight suppress SG assembly is
via an effect on translation. Many of the stresses that trigger SG
formation are thought to act via decreases in translation (Panas
et al., 2016; Protter and Parker, 2016). This decrease in trans-
lation, in turn, leads to transcript release from polysomes en-
abling trans RNA–RNA, RNA–protein, and protein–protein
interactions to nucleate SGs. This release step is believed to be
critical for SG formation, since treatment with cycloheximide
can prevent SG formation (Wheeler et al., 2016). If AdoMet acted
Begovich et al. Journal of Cell Biology 7 of 22
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Figure 4. 59 UTR mRNA-associated SG proteins are not recruited to SGs under high AdoMet levels under growth to 1 d. (A) Quantification and
representative fluorescence images of endogenously expressed GFP-tagged SG proteins in WT and ado1Δ strains at 1-d time point. (B)Western blot analysis of
strains used in A at 1-d time point. Numbers below eachmutant indicate clone number for that genotype. Pgk1 was used as a loading control. (C)Quantification
of proteins levels from B. Protein expression for each protein is normalized to the WT sample. (D) Quantification of mRNA levels in WT and ado1Δ strains using
qPCR analysis. (E) Quantification and representative fluorescence images of endogenously expressed Ded1-GFP in logarithmically growing WT and ado1Δ
strains subjected to acute stress. (F) Quantification and representative fluorescence images of endogenously expressed Ded1-GFP in logarithmically growing
WT and ado1Δ strains subjected to heat shock. Bar graphs in A and C–F are presented as average ± SEM of three independent replicates. Scale bars in A, E, and
F are 5 µm. Statistical significance in A, C, and D was determined by one-tailed paired Student’s t test (*, P < 0.05).
Begovich et al. Journal of Cell Biology 8 of 22
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at the level of translation, wewould predict that polysome traces
would still be intact in AdoMet-supplemented cultures when
cells are exposed to azide. However, polysomes are absent in
both azide-treated cells and cells that were grown with AdoMet
before azide treatment (Fig. 5 H). AdoMet was also unable to
relieve translational repression in glucose-starved cells, high-
lighting that this effect is not stress specific (Fig. S4 D). Thus,
AdoMet plays a role in regulating SG assembly downstream of
the inhibition of translation. Together, these results argue that
AdoMet has two distinct effects on yeast SGs: an acute effect that
suppresses SG formation and a late growth-stage effect that
alters the expression of Ded1 and the recruitment of a subset of
SG proteins.
AdoMet affects SG fusion in cultured mammalian cells
While AdoMet is an abundant, conserved metabolite, the as-
sembly pathway for SGs differs between yeast and mammalian
cells. Yeast SGs assemble via accretion/enlargement of an initial
nucleation event (Wheeler et al., 2016). In contrast, mammalian
SGs form via the fusion of many small SGs (Ivanov et al., 2003).
This difference in dynamics suggested that the regulation of SG
assembly by AdoMet might be specific to yeast. Because there is
Figure 5. Exogenous AdoMet suppresses acute stress-induced SGs. (A) Representative fluorescence images of endogenously expressing GFP-tagged SG
proteins upon azide treatment after growing logarithmically in the presence or absence of 250 µM AdoMet. (B) Quantification of cells with foci from A.
(C)Quantification of the number of foci/cells from A. (D)Western blot analysis from strains used in A. (E) Representative fluorescence images of endogenously
expressed Ded1-GFP in WT and hmt1Δ strains upon azide treatment. Pgk1 serves as a loading control. (F) Quantification of cells with foci from E.
(G) Quantification of the number of foci/cell from E. (H) Polysome traces from cultures that were subjected to azide treatment after growing logarithmically in
the presence or absence of 250 µM AdoMet. Bar graphs in B, C, F, and G are presented as average ± SEM of three independent replicates. Scale bars in A and E
are 5 µm. Statistical significance in B, C, F, and G was determined by one-tailed paired Student’s t test (*, P < 0.05).
Begovich et al. Journal of Cell Biology 9 of 22
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no known stationary phase–like stress that can induce SGs in
mammalian cells, we tested effects of AdoMet on SGs that form
in response to acute stress. Pretreatment of either HeLa or U2OS
cells with 4 mM AdoMet before oxidative stress with 500 µM
sodium arsenite caused a shift from a small number of large SGs
(−AdoMet) to a large number of small SGs (+AdoMet; Fig. 6, A, B,
D, and E). Although shorter pretreatments with AdoMet affected
SG formation in both HeLa and U2OS cells, the extent of the
effect differed between the cell types. 15-, 30-, and 60-min
pretreatment of HeLa cells with AdoMet before arsenite stress
caused an increase in the number of small SGs in HeLa cells,
with the maximal effect at 30 min (Fig. S5 A). In contrast to a
longer AdoMet incubation, pretreatment of U2OS cells with
AdoMet for 30 or 60 min before oxidative stress reduced the
number of cells with SGs (Fig. S5 B), whereas a 3-h AdoMet
incubation did not affect the number of cells with SGs. AdoMet
treatment had no effect on the expression level of either G3BP1
or DDX3 in HeLa cells, arguing that the changes we observed in
this cell line are not secondary to global changes in the levels of
SG components (Fig. 6 C). Thus, AdoMet regulates SG assembly
in both yeast and mammalian cells.
Because the composition ofmammalian SGs varies depending
on the type of stress and the cell type, we next explored whether
AdoMet affected the dynamics of SGs that form in response to
proteotoxic stress (MG132; Mazroui et al., 2007) or translational
stress (rocaglamide [RocA]; Aulas et al., 2017). Pretreatment of
HeLa cells with AdoMet caused an increase in SG number and a
decrease in SG size for both proteotoxic and translational stress
(Fig. 6, A and B). Thus, AdoMet pretreatment has the same effect
on SG formation in HeLa cells for all three stresses we have
tested. In contrast, AdoMet treatment decreases the percentage
of U2OS cells that form SGs in response to the translational in-
hibitor, RocA, by approximately fourfold (Fig. 6, D and F). Be-
cause MG132 was unable to induce SGs in U2OS cells, we were
unable to assay the effect of AdoMet on proteotoxic stress in
these cells (data not shown). These results argue that cell type
differences might modulate both SG formation and the response
to AdoMet. Additionally, our results in HeLa cells suggest that
AdoMet treatment disrupts a step in SG formation that is com-
mon to several different stress conditions.
That the AdoMet treatment causedmany small SGs to form in
response to a variety of stresses suggested that AdoMet treat-
ment might be disrupting the fusion step in SG formation. If this
were the case, the number and size of SGs would be relatively
constant throughout the duration of the stress for AdoMet-
pretreated cells, whereas in untreated cells, the number of SGs
would fall as the SGs become larger owing to SG fusion. As
predicted, the number of SGs decreased in untreated cells over
the course of 1 h after arsenite treatment, whereas the number of
SGs in AdoMet-treated cells remained largely constant (Fig. 7 A).
Similarly, in untreated cells, we observed that the average size of
SGs increased 1 h after arsenite treatment. In contrast, the av-
erage size of SGs in AdoMet-treated cells remained largely
constant (Fig. 7 B). Although these results are consistent with
AdoMet treatment altering the dynamics of SG fusion, it is also
possible that AdoMet treatment might be buffering the oxidative
stress due to arsenite. If this were the case, we would expect
AdoMet treatment to decrease eIF2a phosphorylation after ar-
senite treatment. However, AdoMet treatment has no effect on
the extent of eIF2a phosphorylation, implying that AdoMet is
not buffering oxidative stress or disrupting the earliest steps in
SG formation (Fig. 7, C and D). Together, these results argue that
AdoMet treatment disrupts the fusion step of mammalian SG
formation in HeLa cells.
Because relatively little is known about how SG fusion is
regulated, we tested whether AdoMet could be acting via effects
on the cytoskeleton and/or protein methylation. Previous
studies have found that SG fusion is microtubule dependent
(Ivanov et al., 2003), suggesting that AdoMet could act via ef-
fects of the microtubule cytoskeleton (Ivanov et al., 2003).
However, AdoMet treatment did not cause an obvious defect in
microtubule organization in HeLa cells (Fig. 7 E). Furthermore,
the effects of AdoMet treatment on SG size and number were
additive with those of the microtubule-depolymerizing drug,
nocodazole (Fig. 7, E and F). This argues that AdoMet acts at a
step that is distinct from the microtubule-dependent step of SG
fusion.
One of the potential effects of AdoMet treatment is an in-
crease in protein methylation. Given that SG formation and
composition are known to be regulated by arginine methylation
within RGG domains of SG components (Tsai et al., 2016), we
next examined whether AdoMet could be acting via protein
methylation. To test this possibility, we treated HeLa cells with
AdoMet in the presence of the broad-spectrum methyltrans-
ferase inhibitor, adenosine dialdehyde (AdOx). Interestingly,
AdoMet continued to robustly disrupt SG fusion in the presence of
AdOx (Fig. 8). Thus, the effects of AdoMet on SG fusion in HeLa
cells occur independently of the majority of methyltransferases.
AdoMet reduces SG formation in iPSC-derived MNs
Because both cell type and stress appeared to modulate the ef-
fects of AdoMet, we sought to test the effects of AdoMet on SG
formation in cells where misregulation of SGs is linked to dis-
ease. Recent genetic studies have identified ALS-linked muta-
tions in several RNA binding proteins (RBPs) that are either
found in or regulate SGs, including TDP-43, FUS, and hnRNPA1/
A2 (Kim et al., 2013; Kwiatkowski et al., 2009; Martinez et al.,
2016; Sreedharan et al., 2008; Vance et al., 2009). ALS-
associated mutations within these RBPs increase the conver-
sion of phase-separated liquid droplets to form solid fibrillar
structures in vitro (Lin et al., 2015; Molliex et al., 2015; Patel
et al., 2015; Ryan et al., 2018) and increase SG assembly in cells
(Kim et al., 2013). Neurons that contain these mutated RBPs and
are continuously exposed to a lifetime of stress are thought to
accumulate insoluble, pathological inclusions that contain many
SG proteins. To test the effect of AdoMet on SG dynamics in
ALS-associated MNs, we differentiated MNs using our previ-
ously established protocol (Martinez et al., 2016) from iPSC lines
derived from patients with ALS-associated mutations in either
TDP-43 (N352S) or FUS (R521G). The effects of AdoMet on ar-
senite- and puromycin-induced SGs were then examined and
compared with control MNs from iPSC lines derived from a
genetically related, but unaffected, family member and an un-
related healthy individual. AdoMet treatment reduced both the
Begovich et al. Journal of Cell Biology 10 of 22
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Figure 6. AdoMet supplementation regulates SG assembly in HeLa and U2OS cells. (A) Representative immunofluorescence images of AdoMet-treated or
nontreated HeLa cells stressed with 500 µM NaAsO2, 100 µM MG132, or 2 µM RocA and stained for DDX3 and G3BP1. (B) Box plot displaying the number of
SGs/cell and average SG size from A. (C) Western blot analysis from HeLa cell lysates of AdoMet-treated and untreated cells. Values represent normalized
protein levels of AdoMet-treated to untreated samples. Actin serves as a loading control. (D) Representative immunofluorescence images of AdoMet-treated or
untreated U2OS cells stressed with 500 µMNaAsO2 or 2 µM RocA and stained for DDX3 and G3BP1. (E) Box plot displaying the number of SGs/cell and average
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number of SGs/cell as well as the total SG area/cell in both
stresses (Fig. 9, A–D). Thus, AdoMet disrupts SG formation in
MNs, and the effect is independent of the stress, unlike in HeLa
and U2OS cells.
A hallmark of ALS includes the mislocalization of nuclear
TDP-43 to cytoplasmic inclusions in spinal MNs of ALS patients
(Bentmann et al., 2012; Blokhuis et al., 2013; Farg et al., 2013;
Keller et al., 2012; Kim et al., 2013; Liu-Yesucevitz et al., 2010).
MNs derived from ALS patients in both our study and previous
studies exhibited prolonged cytoplasmic accumulation of TDP-
43 following recovery from puromycin stress compared with
MNs derived from healthy individuals (Fang et al., 2019). As a
result, we next examined if AdoMet treatment affected TDP-43
recruitment to SGs in addition to decreasing the number of SGs
that form. Interestingly, the SGs that formed in response to
puromycin fail to recruit TDP-43 when the iPSC-derived MNs
were pretreated with AdoMet. This effect was specific to TDP-
43, as recruitment of Ataxin-2 to SGs was unaffected in AdoMet-
pretreated iPSC-derived MNs (Fig. 9, E and F). Thus, in addition
to decreasing SG formation, AdoMet treatment decreases the
recruitment of TDP-43 to SGs that form in response to stress.
Discussion
SGs are believed to play a critical role in modulating gene ex-
pression programs in response to environmental and nutrient
stresses. However, it has been unclear how changes in cellular
activity regulate SG formation and composition. Our finding that
Sam1 is recruited to yeast SGs in response to a specific nutrient
stress and that the product of Sam1, AdoMet, regulates SG for-
mation in both yeast and human cells suggests that the con-
nections between metabolism and SG assembly might be
broader than previously believed.
Stress-specific recruitment of metabolic enzymes to SGs
Recent work on the SG proteome suggests that SG composition
can vary depending on the cell type and the nature of the stress
(Markmiller et al., 2018). Because many of the stresses that
trigger SG assembly are thought to alter metabolic activity, ei-
ther directly or indirectly, one might expect metabolic enzymes
to be a common component of SGs. However, few metabolic
enzymes have been identified in proteomic and targeted studies
of Saccharomyces cerevisiae SGs (Jain et al., 2016; Markmiller
et al., 2018; Noree et al., 2019; Saad et al., 2017). Our identifi-
cation of 17 metabolic enzymes that are recruited to SGs in re-
sponse to physiological nutrient stresses, but are not recruited to
SGs in response to multiple acute stresses, argues that SG
composition is tailored to the nature of the stress and that
chronic stresses might require reorganization of the metabolic
network.
This result also helps to explain why no metabolic enzymes
have been identified in previous proteomic studies of mamma-
lian SGs. All of the stresses that are traditionally used to induce
mammalian SGs, such as sodium azide, do not trigger the re-
cruitment of metabolic enzymes to yeast SGs. Thus, one might
expect to observe metabolic enzymes only in SGs that assemble
in response to the mammalian equivalent of a stationary-phase
nutrient stress.
Future studies directed at defining physiological nutrient
stresses that induce SGs inmammalian cells would likely expand
the connections between the SG proteome and metabolism.
Given that the recruitment of metabolic enzymes to SGs in
yeast is stress specific, one might expect that additional target-
ing mechanisms were used for this class of proteins. Consistent
with this, the metabolic enzymes recruited to SGs are not en-
riched in either IDR or LCS sequences relative to metabolic en-
zymes that are not targeted to SGs. Furthermore, the majority of
the SG-associated metabolic enzymes do not possess a predicted
RNA binding domain and have not been identified in high-
throughput screens as RBPs. Thus, it is likely that the presence
of neither IDR nor LCS sequences is sufficient to target these
metabolic enzymes to SGs and that the recruitment mecha-
nism is likely to involve additional stress-specific interaction
domains.
Biphasic AdoMet regulation of yeast SG assembly
The stress-specific recruitment of metabolic enzymes suggested
a novel route to identify metabolic pathways that might play a
role in regulating SG assembly. Our focus on the product of
Sam1, AdoMet, has uncovered unexpected parallels between
how metabolites regulate metabolism and SG formation/com-
position. Metabolite regulation of metabolic pathway activity is
biphasic. Critical metabolites can directly regulate enzyme ac-
tivity over short time scales, but they also cause changes in the
expression profile of a pathway when the metabolite is present
or absent for long periods of time. Interestingly, we observed a
similar two-phase regulation of SG formation and composition
by AdoMet.
Brief treatments of log phase yeast with AdoMet were able to
block SG formation in response to acute stresses without af-
fecting expression levels of SG proteins. In contrast, genetic
manipulations that caused sustained alterations in AdoMet
levels affected the expression of the SG nucleator, Ded1. For
instance, mutations in SAM1 that decrease AdoMet production
increase Ded1 protein levels. Because overexpression of Ded1 is
known to trigger SG assembly (Hilliker et al., 2011), the increase
in SG formation when AdoMet levels fall is likely due to its effect
on Ded1 expression. Conversely, the deletion of ADO1 in diauxic-
phase cultures causes an increase in AdoMet levels and a re-
duction in both Ded1 protein levels and its localization to SGs.
SG size in response to arsenite stress from D. (F) Quantification of U2OS cells containing SGs in response to RocA treatment from D. Data are presented as
average ± SEM of three independent replicates. Box plots in B and E are a compilation of three independent experiments. Scale bars in A and D are 10 µm.
Statistical significance in B, E, and F was determined by one-tailed unpaired Student’s t test, and in F, one-tailed paired Student’s t test (*, P < 0.05). For box
plots, the ends of the box mark the 25th and 75th percentiles. The median is marked by a horizontal line inside the box. The whiskers mark the minimum and
maximum measurements.
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Figure 7. SGs are unable to properly fuse in AdoMet-treated HeLa cells. (A) Box plots depicting the number of SGs/cell in HeLa cells after the addition of
500 µM NaAsO2. Gray boxes represent HeLa cells treated with AdoMet before stress. White boxes represent the untreated control. (B) Box plots depicting the
average SG size at the indicated time points after addition of 500 µM NaAsO2 for both AdoMet-treated (+AdoMet) and untreated (−AdoMet) HeLa cells.
(C) Western blot analysis of HeLa cell lysates from the indicated time points after the addition of 500 µM NaAsO2 from AdoMet-treated and untreated cells.
Actin serves as a loading control. (D) Quantification of proteins levels from C. Data are presented as average ± SEM of three independent replicates.
(E) Representative immunofluorescence images of HeLa cells stained for Tubulin and G3BP1 after treatment with 500 µM NaAsO2-treated conditions. HeLa
cells were treated with or without 4 mMAdoMet for 3 h and then DMSO or 5 µM nocodazole for 2 h before addition of NaAsO2. Scale bar is 10 µM. (F) Box plot
displaying the number of SGs/cell from E. (G) Box plot displaying quantification of the average SG size from E. Box plots in A, B, F, and G represent a compilation
of three independent experiments. Statistical significance in A, B, F, and G was determined by one-tailed unpaired Student’s t test (*, P < 0.05). For box plots,
the ends of the box mark the 25th and 75th percentiles. The median is marked by a horizontal line inside the box. The whiskers mark the minimum and
maximum measurements.
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Interestingly, this effect on Ded1 expression was posttranscrip-
tional, since ado1Δ strains had elevated DED1 transcript levels
even though the levels of Ded1 protein were decreased. Fur-
thermore, aspects of this control loop might be conserved from
yeast to humans, since protein levels of the human orthologue of
Ded1, DDX3, have also been shown to be sensitive to AdoMet
levels in Huh7 cells (Schröder et al., 2012).
These changes in SG composition in response to sustained
elevation of AdoMet are not limited to Ded1. SGs in ado1Δ strain
SGs also lacked other 59 UTR mRNA-associated proteins, in-
cluding eIF4G1 and eIF4E, while SG proteins associated with the
39 UTR of mRNA (i.e., Pab1, Pbp1, and Pub1) were unaffected.
Additionally, SGs in ado1Δ strains were defective in recruiting
Sam1 and Ade17. With the exception of eIF4G1, none of these
recruitment defects were due to a decrease in protein expres-
sion. Thus, sustained increases in AdoMet levels can selectively
block recruitment of a subset of SG components in addition to
down-regulating Ded1. Together, these results argue that Ado-
Met acts at short time scales to suppress SG formation, while
chronic increases in AdoMet modify the SG proteome by
affecting both the expression and recruitment of SG compo-
nents. Interestingly, recent work has also identified acetyl-
CoA as a candidate small-molecule regulator of SGs; however,
its mechanism of action is unclear (Rollins et al., 2017). Future
studies of how acetyl-CoA regulates SG assembly at short and
long time scales will help determine whether biphasic regula-
tion is a common feature of metabolite regulation of yeast SG
formation.
Figure 8. AdoMet’s effect on SG is not linked to protein methylation. (A) Representative immunofluorescence images of HeLa cells stained for DDX3 and
G3BP1 after 500 µM NaAsO2 treatment. Before arsenite stress, HeLa cells were treated with DMSO or 20 µM AdOx for 48 h followed by the addition of 4 mM
AdoMet for 3 h. Scale bar is 10 µM. (B) Box plot displaying the number of SGs/cell from A. (C) Box plot displaying quantification of the average SG size from A.
(D)Western blot analysis from HeLa cell lysates that were treated with DMSO or 20 µM AdOx followed by addition of 4 mM AdoMet. Actin serves as a loading
control. (E) Quantification of total ADMA levels from D. Data are presented as average ± SEM of three independent replicates. Box plots in B and C represent a
compilation of three independent experiments. Statistical significance in B and C was determined by one-tailed unpaired Student’s t test (*, P < 0.05). For box
plots, the ends of the box mark the 25th and 75th percentiles. The median is marked by a horizontal line inside the box. The whiskers mark the minimum and
maximum measurements.
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Figure 9. AdoMet reduces SG formation in iPSC-derivedMNs and reduces TDP-43 accumulation in SGs. (A) Representative immunofluorescence images
of AdoMet-treated or untreated control iPSC-derived MN lines and ALS-associated TDP-43 N352S and FUS R521G mutant iPSC-derived MN lines stained for
TDP-43 and G3BP1 after treatment with 250 µM NaAsO2. (B) Box plots displaying quantification of the number of SGs/cell and total SG area from A.
(C) Representative immunofluorescence images of AdoMet-treated or untreated control iPSC-derived MN lines and ALS-associated TDP-43 N352S and FUS
R521G mutant iPSC-derived MN lines stained for TDP-43 and G3BP1 after treatment with 5 µg/ml puromycin. (D) Box plots displaying quantification of the
number of SGs/cell and total SG area from A. (E) Representative immunofluorescence images of AdoMet-treated or nontreated WT iPSC-derived MN lines
stained for Ataxin 2, G3BP1, and TDP-43 after treatment with 5 µg/ml puromycin. (F) Box plots displaying quantification of the total SG area as measured by
G3BP1, Ataxin-2, and TDP-43 from A. Box plots in B, D, and F represent a compilation of three independent experiments. Scale bars in A, C, and E are 10 µm.
Statistical significance in B, D, and F was determined by one-tailed unpaired Student’s t test (*, P < 0.05). For box plots, the ends of the box mark the 25th and
75th percentiles. The median is marked by a horizontal line inside the box. The whiskers mark the minimum and maximum measurements.
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Although themolecular targets of AdoMet at either time scale
are unclear, our initial characterization suggests that it does not
act via protein methylation. Deletion of the Ded1 methyltrans-
ferase, HMT1, did not block the effect of elevated AdoMet levels.
Similarly, treatment of mammalian cells with the broad-spectrum
methyltransferase inhibitor, AdOx, did not block the effect of
AdoMet on SGs. These experiments raise the possibility that
AdoMet might disrupt SG formation by altering RNA methyl-
ation. Although mRNAs with m6A modifications are recruited
into SGs (Anders et al., 2018; Wang et al., 2015), it remains to be
determined whether the levels of mRNA methylation can alter
the dynamics of SG formation.
Conservation of AdoMet-mediated SG regulation in
mammalian cells
While yeast and mammalian SGs share a significant overlap in
their proteome, not all aspects of composition and regulation are
conserved. For instance, mammalian SGs mature by the fusion
of small SGs into larger SGs, but fusion-based maturation has
not been observed in yeast (Ivanov et al., 2003; Wheeler et al.,
2016). Despite these differences, yeast and mammalian SGs are
both regulated by AdoMet. Treatment of either yeast- or iPSC-
derived MNs with AdoMet suppressed arsenite-induced SG
formation in both cell types, arguing that AdoMet is a conserved
small-molecule regulator of SGs.
Interestingly, although the acute effects of AdoMet on yeast
and iPSC-derived MNs are comparable, AdoMet treatment had
distinct effects on SG formation in cancer-derived cell lines.
Treatment of HeLa cells with AdoMet before oxidative, proteo-
toxic, and translational stress resulted in SGs that were greater
in number and smaller in size. This suggests that AdoMet
treatment disrupts SG fusion in cancer-derived cell lines rather
than blocking SG formation. Furthermore, this effect is micro-
tubule independent, implying that AdoMet treatment is dis-
rupting a novel step in the SG fusion process. One possible
reason that AdoMet treatment disrupts different steps in SG
formation inHeLa cells comparedwith iPSC-derivedMNs is that
cancer cell lines and nondividing primary cells have distinct
metabolic profiles. Future studies examining how basal cell
metabolism alters AdoMet’s effects on SG formation will likely
provide new insights into what makes particular cells sensitive
or resistant to stress.
Most provocatively, AdoMet treatment suppressed SG for-
mation in iPSC-derived MNs that expressed mutated forms of
TDP-43 and FUS found in ALS patients. AdoMet was effective in
blocking SG assembly in these disease models, even though
these mutated forms of TDP-43 and FUS have an increased
propensity to phase separate (Ling et al., 2013; Mackenzie et al.,
2017; Murakami et al., 2015; Patel et al., 2015). Thus, aberrant,
pathogenic SGs are just as sensitive to AdoMet treatment as
normal SGs. This argues that AdoMet acts at a step in SG for-
mation that is common to both the conventional SG assembly
pathway and the pathways used by aggregation-prone variants
of TDP-43 and FUS. Furthermore, the few SGs that form in
mutant MNs pretreated with AdoMet fail to recruit TDP-43.
AdoMet exhibits a planar aromatic moiety similar to other
known active molecules that are known to reduce SG assembly
and block other ALS-associated RBPs (Fang et al., 2019). Thus,
the ability of AdoMet to suppress the formation of pathological
SGs argues that pathways that control either AdoMet levels or
the SG response to AdoMet, presenting an exciting and tractable
therapeutic approach for ALS and other neurodegenerative
diseases.
Materials and methods
Yeast strains and growth
All yeast experiments were performed in S. cerevisiae budding
yeast in the BY4741 background. All yeast strains were grown at
30°C unless otherwise indicated in either YPDmedium (1% yeast
extract, 2% peptone, and 2% dextrose) or synthetic defined (SD)
medium (0.17% yeast nitrogen base without ammonium sulfate
or amino acids, 0.5% ammonium sulfate, amino acids, and 2%
glucose).
A complete list of strains used in this study is given in Table
S4. All yeast strains were derived from a parent strain with the
genotype MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 (BY4741). Gen-
eration of endogenous GFP-tagged strains and gene disruption
was performed using standard PCR-mediated techniques (Wach
et al., 1994). A complete list of oligonucleotides used in this study
is given in Table S5. Strains from the GFP collection (Howson
et al., 2005) were used as background strains for the production
of dual fluorescent–tagged strains used in RNA granule screen.
For all other experiments, newly made strains were generated
using BY4741 (Dharmacon) as the parental strain.
To generate Ded1 and Sam1 mutants, the full-length coding
sequence was amplified from the genomic locus and subcloned
into the pFA6a-GFP-KanMx6 plasmid upstream of the GFP se-
quence. With the resulting plasmids as templates, site-directed
mutagenesis was used to generate point mutations. Ded1-GFP
and Sam1-GFP variants were introduced into their respective
endogenous loci by PCR-amplifying cassettes that contained the
coding sequence of Ded1-GFP or Sam1-GFP, a kanamycin resis-
tance marker, and a 50-bp sequence homologous to downstream
of their respective stop codons. These cassettes were introduced
into yeast using standard yeast transformation protocols. Ge-
nomic DNAwas extracted from resulting transformants, and the
loci were PCR amplified and sequenced to verify the presence of
the correct mutation.
Preparation of samples for yeast microscopy
For acquiring images from RNA granule screen, cells were
grown in YPD at 30°C for 1 and 5 d and fixed before imaging.
Briefly, 0.1 ml 37% formaldehyde was added to 1 ml of culture
and rotated for 15 min at RT. Fixed cells were then spun down
and washed with water before resuspending in 1 M sorbitol.
Cells were stored for up to 1 wk at 4°C or imaged immediately.
For the remaining experiments, live-cell imaging was used. Cells
were grown in indicated medium at 30°C to either log phase or
1-d time point and spun down. Samples were concentrated in
their existing medium, and cells were imaged immediately.
Heat shock, sodium azide, glucose deprivation, and ethanol
shock were performed as described previously with methionine
deprivation under similar conditions. Briefly, cells were grown
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in indicated medium (YPD or SD) overnight at 30°C and then
back-diluted into fresh medium to an OD600 of 0.2 and grown at
30°C to log phase. For heat shock experiments, cells were
transferred to a water bath set at 46°C or remained at 30°C for
10 min. For NaN3 experiments, yeast cultures were treated with
0.5% NaN3 or water for 30 min at 30°C before imaging. For
glucose-deprivation experiments, cells were collected and
washed in 30°C prewarmed medium lacking glucose (YP or SD
Glu−) followed by resuspension again in 30°C prewarmed me-
dium lacking glucose. Cells were then placed back at 30°C for
30 min and then imaged immediately. For ethanol shock, yeast
cultures were collected and washed in 30°C prewarmed SD
medium with ethanol (SD EtOH 6%) as its sole carbon source
followed by resuspension again in 30°C prewarmed SD medium
with ethanol. Cells were placed back at 30°C for 30 min and
imaged immediately. For methionine-deprivation experiments,
cells were collected and washed with 30°C prewarmed SD me-
dium lacking methionine followed by resuspension again in
30°C prewarmed SD medium lacking methionine. Cells were
placed back at 30°C for 30 min and imaged immediately. For
AdoMet-supplemented experiments, yeast cultures were grown
overnight in YPD medium at 30°C and then back-diluted into
YPD with 250 µM AdoMet (Sigma-Aldrich). Cells were then
grown to the desired time point.
RNA isolation and quantitative PCR (qPCR)
Total RNA was obtained by harvesting 40 OD600 units of cells
from the 1-d time point and resuspending pellets in RNA lysis
buffer (10 mM EDTA and 50mMNaOAc, pH 5.5). Next, SDS was
added to a final volume of 1%. Samples were then subjected to a
series of hot acid phenol/chloroform, acid phenol/chloroform,
and chloroform extractions followed by precipitation. 5 µg of
RNA was used to create cDNA using the SuperScript III First-
Strand Synthesis System (Invitrogen) following the manu-
facturer’s protocol. qPCR was performed using SYBR Green PCR
Master Mix (Applied Biosystems). The relative levels of tran-
scripts were calculated using the ΔΔCt method and normalized
to ACT1.
Yeast metabolomics
Metabolite extraction was performed as indicated in Boer et al.
(2010). Briefly, 20 ml of −20°C 100% liquid chromatography–
mass spectrometry (LC-MS)–grade methanol was added to 10 ml
of yeast cultures that were grown to either log phase or 24 h (1-d
time point). Next, samples were spun down at 4,000 rpm for
5 min at −10°C. The supernatant was decanted, and the pellet
was resuspended in −20°C LC-MS–grade extraction buffer (40:
40:20 acetonitrile/methanol/water) and then incubated at 4°C
for 15 min. Resuspensions were pelleted again, and the super-
natant was saved. Extraction buffer was added again to the
pellets and incubated for 15 min. Cells were pelleted again, and
the supernatant was added to the previous fraction and stored at
−80°C.
Quantitative analysis of SAM, AdoMet, and methionine by
LC-MS was performed using conditions previously described
(Vliet et al., 2019). Briefly, analysis was performed on a TQ-XS
triple-quadrupole mass spectrometer (Waters) coupled to an
I-class ultraperformance LC system (Waters). Separations were
performed on a ZIC-pHILIC column (2.1 × 150 mm, 5 µM; EMD
Millipore). The mobile phases were water with 15 mM ammo-
nium bicarbonate adjusted to pH 9.6 with ammonium hydroxide
(A) and acetonitrile (B). The flow rate was 200 µl/min and the
column was held at 50°C. The injection volume was 1 µl. The
gradient was as follows: 0 min, 90% B; 1.5 min, 90% B; 16 min,
20% B; 18 min, 20% B; 20 min, 90% B; and 28 min, 90% B.
The MS was operated in selected reaction monitoring mode.
Source and desolvation temperatures were 150°C and 500°C,
respectively. Desolvation gas was set to 1,000 liter/h and cone
gas to 150 liter/h. Collision gas flow was 0.15 ml/min. All gases
were nitrogen except the collision gas, which was argon. Cap-
illary voltage was 1 kV in positive ion mode. A quality control
sample, generated by pooling equal aliquots of each sample, was
analyzed every three to six injections tomonitor system stability
and performance. Samples were analyzed in random order. Data
were processed using Skyline software (MacLean et al., 2010).
Polysome profile analysis
200 ml of WT cells (BY4741) were grown to log phase (OD600
∼0.5) in YPD medium with or without 250 µM AdoMet (Sigma-
Aldrich) at 30°C. Once cells reached log phase, the 200-ml cul-
ture was split into two flasks containing 100 ml each, and one
was treated with 0.05% sodium azide or switched into medium
lacking glucose (YP) for 30 min at 30°C. Before harvesting, cells
were treated with 100 µg/ml cyclohexamide (Sigma-Aldrich)
and allowed to shake for an additional 2 min at 30°C. Cultures
were then spun down for 5 min at 4,000 rpm at 4°C, and the
pellet was washed and resuspended in 1.5 ml ice-cold polysome
lysis buffer (20 mM Tris-HCl, pH 8.0, 140 mM KCl, 1.5 mM
MgCl2, 100 µg/ml cyclohexamide, and 1% Triton X-100). An
equal volume of acid-washed glass beads was added to the re-
suspensions, and lysis was performed by vortexing samples for
30 s a total of eight times with 1 min of recovery on ice in be-
tween cycles. Lysates were then cleared by centrifuging samples
for 5 min at 2,000 rpm at 4°C. The supernatant was recovered
and then spun for 10 min at 14,000 rpm at 4°C. The supernatant
was collected, and OD260 values were determined using a
NanoDrop Spectrophotometer. 50 OD260 units were then loaded
onto a 10–50% linear sucrose gradient and centrifuged for 3 h at
35,000 rpm at 4°C. Gradients were collected from the top using a
Biocomp Nano Fractionator, which continuouslymeasured A254
values to generate polysome traces.
Mammalian cell culture growth conditions
The HeLa-S3 cell line is derived from human female cervical
adenocarcinoma tissue, and the U2OS cell line is derived from
human female osteosarcoma tissue. Both HeLa and U2OS cell
lines were maintained in DMEM (Gibco), 10% FBS (Corning),
and 1% penicillin/streptomycin (Gibco) at 37°C and 5% CO2 in a
humidified incubator.
Adult human primary fibroblasts carrying TARDBP (N352S)
mutation and from a control individual were obtained by Dr.
John Ravits (University of California, San Diego). Primary fi-
broblasts were cultured in DMEM supplemented with 10% FBS,
nonessential amino acids, and L-glutamine at 37°C and 5% CO2 in
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a humidified incubator. To generate iPSCs, fibroblasts were
transduced with Cytotune iPS Sendai Reprogramming Kit, ac-
cording to the manufacturer’s protocol (Invitrogen). The human
iPSC line carrying ALS-associated FUS (R521G) mutation was
previously reprogrammed from primary fibroblasts obtained by
Franca Cambia, Edward Kasarskis, and Haining Zhu (University
of Kentucky, Lexington, KY), as described (Kapeli et al., 2016).
All iPSCs were maintained on Matrigel-coated plates (BD Bio-
sciences) inmTeSR1 growthmedium (Stem Cell Technologies) at
37°C and 5% CO2 in a humidified incubator. Colonies were ex-
panded by clump-passaging using enzyme-free dissociation
buffer (EDTA). Informed consent was obtained from all in-
dividuals before sample collection. The use of patient fibroblasts
for research was approved by the University of California, San
Diego Institutional Review Board.
Generation of iPSC-derived MNs
Human MNs were differentiated from iPSCs as previously de-
scribed (Markmiller et al., 2018). Briefly, immediately before
differentiation, iPSCs were passaged with Accutase (StemCell
Technologies) and grown as a monolayer on feeder-free plates in
mTeSR1. Once the cells reached >90% confluence, medium was
changed daily with N2B27 medium (DMEM/F12 + GlutaMAX
[Life Technologies], 1% N-2 supplement, 2% B-27 supplement
[Thermo Fisher Scientific], 200 µM ascorbic acid [Sigma-
Aldrich], and 1% penicillin/streptomycin) and supplemented
with 1 µM dorsomorphin dihydrochloride, 10 µM SB431542, and
4 µM CHIR99021 (Tocris) for 6 d. From day 7 to 18, cells were fed
daily with N2B27 medium supplemented with 1 µM dorsomor-
phin dihydrochloride, 10 µM SB431542, 200 nM smoothened
agonist (SAG; Tocris), and 1.5 µM retinoic acid (RA; Sigma-
Aldrich). On day 18, cells were dissociated using Accutase and
transferred to plates coated first with 0.001% wt/vol poly-D-
lysine hydrobromide and poly-L-ornithine (Sigma-Aldrich)
overnight, followed by an overnight incubation of 20 µg/ml
laminin (Life Technologies) at 37°C, 5% CO2. The dissociated cells
were seeded in N2B27 medium supplemented with 2 ng/ml re-
combinant human brain-derived neurotrophic factor, 2 ng/ml
recombinant human glial cell line–derived neurotrophic factor,
2 ng/ml recombinant human ciliary neurotrophic factor (Pe-
proTech), 1.5 µM RA, 200 nM SAG, and 10 µM Y-26732 ROCK
inhibitor (Tocris). On day 20,mediumwasmodified by reducing
ROCK inhibitor to 2 µM. On day 22, RA and SAGwas withdrawn,
and 2 µM N-[N-(3,5-difluorophenacetyl-L-alanyl)]-S-phenylglycine
t-butyl ester (DAPT; Tocris) was added to themedium. For imaging,
cells were replated sparsely onto poly-D-lysine hydrobromide/poly-
L-ornithine/laminin-coated 8-well glass chamber slides (Millipore)
in the samemedium on day 24. At 26 d, DAPTwaswithdrawn from
the medium.
Mammalian cell immunofluorescence
HeLa and U2OS cells were passaged and plated onto glass cov-
erslips in 12-well plates and grown for 24 h. For AdoMet treat-
ment, 4 mM AdoMet was added to wells for 3 h before the
application of stress or nocodazole (Sigma-Aldrich). For AdOx
experiments, cells were grown in the presence of 20 µM before
addition of AdoMet. To induce SG formation, sodium arsenite
(Sigma-Aldrich) was added to a final concentration of 500 µM
and incubated for 1 h. For MG132 (Sigma-Aldrich) and RocA
(Sigma-Aldrich) experiments, cells were incubated with com-
pounds for 2 h in a final concentration of 100 µM and 2 µM,
respectively. Cells were then washed with PBS and fixed in 4%
PFA (Sigma-Aldrich) for 20 min. After removal of fixative, cells
were washed with PBS and then permeabilized in 0.5% Triton
X-100/PBS for 15min. After permeabilization, cells werewashed
with PBS and then incubated with blocking solution (4% BSA/
PBS) for 30 min. Primary antibodies (1:100 mouse anti-DDX3,
Santa Cruz Biotech, sc-365768; and 1:1,000 rabbit anti-G3BP1,
Sigma-Aldrich, G6046) were diluted in blocking solution and
added to cells overnight at 4°C. After PBS washes, secondary
antibodies (1:200 donkey anti-rabbit 568, Invitrogen, A10042;
and 1:200 goat anti-mouse 488, Invitrogen, A-11029) were in-
cubated for 2 h in the dark. Cells were washed with PBS, and
DAPI was added before mounting coverslips with Vectashield
(Vector Laboratories).
On day 28 of culture, iPSC-derivedMNswere pretreatedwith
4 mM AdoMet for 3 h before the addition of 250 µM sodium
arsenite for 1 h or 5 µg/ml puromycin for 24 h. After stress, cells
were fixed with 4% PFA for 45 min at RT. After three washes
with PBS, the cells were simultaneously blocked and per-
meabilized with 5% goat serum, 0.1% Triton X-100, and 1× PBS
for 1 h at RT. Cells were rinsed with oncewith PBS and incubated
with primary antibody (1:500 mouse anti-TARBP, Abnova,
H00023435-M01; and 1:1,000 rabbit anti-G3BP1, Sigma-Aldrich,
G6046) diluted in 0.01% Triton X-100, 5% goat serum, and 1×
PBS overnight at 4°C. After five washes with 0.01% Triton X-100
and 1× PBS, secondary antibody (1:1,000 goat anti-mouse Alexa
Fluor 488, Invitrogen, A-11029; and goat anti-rabbit Alexa Fluor
555, Invitrogen, A-21428) diluted in 0.01% Triton X-100, 5% goat
serum, and 1× PBS was added for 1 h at RT. Cells were washed
10 times in 0.01% Triton X-100 and 1× PBS before nuclei stain
with DAPI (1:5,000 vol/vol in PBS) for 15 min at RT. After one
wash with 1× PBS, cells were preserved in 50% vol/vol glycerol
in PBS.
Western blot analysis
For yeast samples, whole-cell extracts were prepared via NaOH
extraction as indicated in Kushnirov (2000). Cells were grown
in YPD medium at 30°C to either log phase or 1-d time point.
Next, 1 OD600 (log phase) or 2.5 OD600 (1 d) was spun down and
resuspended in 0.1 N NaOH. After incubation at RT for 5 min,
cells were spun down and then resuspended in 2× sample buffer
with protease inhibitors (Sigma-Aldrich). Samples were boiled
for 5 min at 95°C and incubated on ice for 3 min before cen-
trifugation once more. Supernatants were stored at −20°C or
used immediately.
For HeLa cells, lysates were obtained by first rinsing cells
with cold 1× PBS to remove debris and medium. Next, radio-
immunoprecipitation assay buffer (50 mM Tris-HCl, pH 7.5,
150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1%
SDS, and 2 mM EDTA) with protease inhibitors was added, and
cells were scraped and centrifuged for 10 min at 15,000 rpm at
4°C. Protein concentration was then determined by Bradford
assay (Bio-Rad Protein Assay Dye Reagent Concentrate) and
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normalized across samples. Next, 4× sample buffer was added,
and samples were boiled for 5 min at 95°C and placed on ice for
3 min before centrifugation. Samples were stored at −20°C or
used immediately.
Samples were resolved on 10% SDS-PAGE gels and subse-
quently transferred to nitrocellulose membrane using semidry
conditions. Membranes were then incubated in blocking solu-
tion (5% milk in TBST 0.1%) for 1 h. After TBST 0.1% washes,
membranes were incubated in primary antibody overnight at
4°C: 1:5,000 rabbit anti-GFP (Torrey Pines Biolabs, TP401), 1:2,500
mouse anti-mCherry (Novus Biologicals, NBP1-96752), 1:10,000
mouse anti-PGK1 (Invitrogen, 459250), 1:500 mouse anti-DDX3
(Santa Cruz Biotech, sc-365768), 1:10,000 rabbit anti-G3BP
(Sigma-Aldrich, G6046), 1:500 mouse anti-ACTA (Developmental
Studies Hybridoma Bank, JLA20), 1:1,000 rabbit anti-eIF2α (Cell
Signaling Technology, 9722S), 1:1,000 rabbit anti-phospho-eIF2α
Ser51 (Cell Signaling Technology, 3398S), and 1:1,000 rabbit-
ADMA (Cell Signaling Technology, 13522S). Primary antibody
was removed and washed with TBST 0.1% before adding HRP-
conjugated secondary antibody (1:10,000 donkey anti-rabbit, In-
vitrogen, A16023; and 1:2,500 sheep anti-mouse, Abcam, ab6808)
in 5% blocking solution for 2 h at RT. Membranes were then
washed with TBST 0.1% and then incubated in Thermo Fisher
Scientific Pierce ECL Western Blotting Substrate. Chemilumines-
cence was detected using FluorChem E system (Protein Simple).
Quantification of protein levels was performed using densitome-
try methods by comparing signals to internal control signal (PGK1
for yeast samples or actin for HeLa cells).
Microscopy and image analysis
All images (with the exception of MN experiments) were ac-
quired on a Zeiss Axiovert 200M fluorescent microscope
equipped with a CSU-X1 spinning disk (Yokogawa), a Chrome-
MLE laser source (Toptica Photonics), and μManager v1.4 soft-
ware at RT. For acquisition of yeast, a 2-µm Z-stack was taken
with slices at 0.25-µm intervals using a Nikon 40× 0.65-NA oil
(or 100× 1.25-NA oil for intensity ratio determination) objective.
Mammalian cell images were acquired by taking slices at 0.3-µm
intervals to obtain a 3-µm Z-stack using the 40× 0.65-NA oil
objective. Images for MNs were acquired on a Nikon Ti2 mi-
croscope equipped with a Nikon Qi2 Camera, Lumencor Spec-
traX LED light engine, Semrock quad bandpass filter cube with
barrier filters, and NIS Elements v5.11 software. Images were
taken using a Nikon 40× 0.95-NA objective at RT. For acquisi-
tion, five random nonoverlapping positions within each well of a
96-well plate were generated. At each position, an autofocusing
routine was run to identify the Z-plane with the highest contrast
in the 405-nm channel, and a symmetrical 7-µm-thick Z-stack
centered around this focal plane with 0.9-µm steps was
captured.
For all images, optimal Z-projections were obtained using Fiji
along with subsequent image analysis. Colocalization quantifi-
cation was determined manually as the percentage of the
number of GFP foci overlapped withmCherry foci divided by the
total number of GFP foci. To determine intensity ratio analysis,
maximum intensities of foci were measured along with the av-
erage intensity of the cytoplasm of that cell. Each value was
background-corrected by subtracting the average intensity of
the image with no cell. Intensity ratios were calculated by di-
viding the corrected foci intensity by the corrected cytoplasm
intensity.
For mammalian cell image analysis, single cells were isolated
using the freehand selection tool in Fiji. The number and size of
foci as well as total SG area were then determined using the Fiji
3D Objects Counter plugin. Data were exported to Microsoft
Excel and pooled for further analysis.
Quantification and statistical analysis
One-tailed paired Student’s t test was used when comparing the
averages between two samples. For dot plot and box plot
analysis, Welch’s t test for unequal size and variance and one-
tailed unpaired Student’s t test were used to determine the
significance, respectively. Data distribution was assumed to be
normal, although this was not formally tested. Statistical analysis
was performed using GraphPad Prism 7 software.
Online supplemental material
Fig. S1 summarizes the effects of the SAM1 D121N mutation on
Sam1 and Sam2 recruitment to SGs. Fig. S2 highlights the effects
of AdoMet manipulation on the metabolites in the methionine
biosynthetic pathway. Fig. S3 compares the effects of high
AdoMet levels on the foci formation of P-bodies and metabolic
enzymes found to associate with SGs. Fig. S4 illustrates that
AdoMet-mediated suppression is stress specific and time de-
pendent in yeast. Fig. S5 compares the time-dependent effects of
AdoMet on arsenite-induced SGs in mammalian cells. Table S1
lists the results of the metabolic enzyme-RNA granule screen.
Table S2 shows the domain analysis of metabolic enzymes
identified in the RNA granule screen. Table S3 displays the do-
main analysis of metabolic enzymes with low to no colocaliza-
tion with RNA granules. Table S4 lists the strains used in this
study. Table S5 displays the oligonucleotides used in this study.
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Figure S1. Mutation in the ATP binding domain of Sam1 inhibits recruitment of Sam1 and Sam2 to SGs. (A) Domain organization of Sam1 protein noting
the location of inactivating point mutations. (B) Representative fluorescence images of endogenously expressed WT or mutant Sam1-GFP. (C) Dot plot
displaying foci-to-cytoplasm ratios for endogenously expressed WT and mutant alleles of Sam1-GFP. Red lines mark median value. (D) Representative flu-
orescence images of colocalization endogenously expressedWT or D121N Sam1-GFP with RFP-tagged Sam2, Ade17, Ded1, or Pbp1. (E) Dot plot displaying foci-
to-cytoplasm ratios for endogenously expressed RFP-tagged Sam2, Ade17, Ded1, and Pbp1 in both WT and SAM1 D121N backgrounds. Red lines mark median
value. Scale bars in B and D are 5 µM. Statistical significance in C and E was determined by one-tailed Welch’s t test (*, P < 0.05).
Begovich et al. Journal of Cell Biology S2
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Figure S2. Genetic disruptions of SAM1 and ADO1 result in changes in methionine biosynthetic pathway intermediates. (A) Quantification of me-
thionine and AdoMet from WT, 250 µM-treated WT, SAM1 D121N, 250 µM-treated SAM1 D121N, and ado1Δ strains at 1-d time point. Values are normalized to
WT samples. (B) Quantification of methionine and AdoMet fromWT, 250 µM-treated WT, and ado1Δ strains at log phase. Bar graphs are presented as average
± SEM of three independent replicates. Values are normalized to WT samples. Statistical significance was determined by one-tailed paired Student’s t test
(*, P < 0.05).
Begovich et al. Journal of Cell Biology S3
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Figure S3. Characterization of the SG phenotype in ado1Δ strains. (A) Quantification of cells with Ded1-GFP foci in WT, hmt1Δ, ado1Δ, and ado1Δ;hmt1Δ
background strains at 1-d time point. (B) Quantification of cells with foci in WT and ado1Δ backgrounds expressing either WT or RK 4 Ded1-GFP.
(C) Quantification of cells with foci for P-body markers (Dcp2 and Edc3) in WT and ado1Δ background strains at 1-d time point. (D) Representative images from
D. (E) Quantification and representative fluorescent images of WT and ado1Δ strains with GFP-tagged metabolic enzymes at 1-d time point. *, P < 0.05.
(F)Western blot analysis of strains used in E at 1-d time point. (G) Quantification of proteins levels from F. Pgk1 serves as a loading control. (H) Representative
fluorescent images of WT or ado1Δ strains expressing Cdc19-GFP and Pbp1-mRuby at 1-d time point. (I) Quantification of the degree of colocalization of Cdc19-
GFP foci to Pbp1-mRuby foci in WT and ado1Δ strains. (J) Representative fluorescent images of WT or ado1Δ strains expressing Cys4-GFP and Pbp1-mRuby at
1-d time point. (K) Quantification of the degree of colocalization of Cys4-GFP foci to Pbp1-mRuby foci in WT and ado1Δ strains. Bar graphs in A–C, E, G, I, and K
are presented as average ± SEM of three independent replicates. Scale bars in D, E, H, and J are 5 µM. Statistical significance in E was determined by one-tailed
paired Student’s t test (*, P < 0.05).
Begovich et al. Journal of Cell Biology S4
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Figure S4. Stress-specific and time-dependent effects of AdoMet treatment on acute-induced SG formation in yeast. (A) Quantification of azide-
induced SG formation in non–AdoMet-treated cells (Control) or cells treated with 250 µM AdoMet at the indicated time point before azide addition.
(B) Quantification and representative fluorescent images of logarithmically growing with (AdoMet) or without (Control) 250 µM AdoMet strains expressing
Ded1-GFP upon glucose deprivation. (C) Quantification and representative fluorescent images of logarithmically growing with (AdoMet) or without (Control)
250 µM AdoMet strains expressing Ded1-GFP upon heat shock. (D) Polysome traces from logarithmically growing strains with or without 250 µM AdoMet
under unstressed or glucose deprived (Glucose–) conditions. Bar graphs in A–C presented as average ± SEM of three independent replicates. Scale bars in A and
B are 5 µM. Statistical significance in A and B was determined by one-tailed paired Student’s t test (*, P < 0.05).
Begovich et al. Journal of Cell Biology S5
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Five tables are provided online. Table S1 shows colocalization analysis of hits from RNA granule screen. Table S2 shows domain
analysis of hits from RNA granule screen. Table S3 shows domain analysis of non-hits from RNA granule screen. Table S4 lists yeast
strains used in this study. Table S5 lists the oligonucleotides used in this study.
Figure S5. Time-dependent effects of AdoMet treatment on arsenite-induced SG formation in mammalian cells. (A) Box plots displaying quantification
of number of SGs/cell and average SG size of HeLa cells treated with or without 4 mM AdoMet at the indicated time point before 500 µM NaAsO2 for 1 h. Box
plots represent a compilation of three independent experiments. (B) Quantification of U2OS cells containing SGs treated with or without 4 mM AdoMet at the
indicated time point before 500 µM NaAsO2 for 1 h. Data are presented as average ± SEM of three independent replicates. In A, statistical significance was
determined by one-tailed unpaired Student’s t test, and in B, one-tailed paired Student’s t test (*, P < 0.05). For box plots, the ends of the box mark the 25th
and 75th percentiles. The median is marked by a horizontal line inside the box. The whiskers mark the minimum and maximum measurements.
Begovich et al. Journal of Cell Biology S6
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